Conversely, exosomes from breast cancer cells can have an impact on myofibroblast differentiation from mesenchymal stem cells, accompanied by the increased expression of tumour-promoting factors, including VEGF and TGF-β (60). This evidence concerns the gene VEGFA and breast carcinoma.